Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-21

Clinical Trial Update: Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing rosiglitazone/metformin combination therapy to rosiglitazone with metformin therapy in adults with Type 2 diabetes, evaluating efficac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosiglitazone (rosiglitazone)
  • Rosiglitazone/metformin (combination) (rosiglitazone/metformin)
  • metformin (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED